News
Most Read

Atossa reports positive results from Covid-19 nasal spray study
Leidos to conduct clinical trials for Covid-19 therapeutics
Pfizer and BioNTech to test Covid-19 vaccine against new variants

Most Recent

Clinical Trials

Atossa reports positive results from Covid-19 nasal spray study

26 Feb 2021
Analysis
Sections

Features
Comment
Projects
Most Read

Rare diseases: how can decentralisation speed up trials and reduce patient burden?
IQVIA’s Nagaraja Srivatsan: decentralised trials and the future of clinical research
Neurology trends: Stroke leads Twitter mentions in Q4 2020

Most Recent

Clinical Trials

Rare diseases: how can decentralisation speed up trials and reduce patient burden?

26 Feb 2021
Sectors
Sections

Clinical Trials
Approvals
Clinical Research
Operations
Outsourcing
Supply Chain
Cold Chain
Data Management
Medical Devices
Most Read

Atossa reports positive results from Covid-19 nasal spray study
Leidos to conduct clinical trials for Covid-19 therapeutics
South and Central America accounts for 2.8hare of global clinical trial activity in 2020

Most Recent

Clinical Trials

Atossa reports positive results from Covid-19 nasal spray study

26 Feb 2021
Themes
Deals
Most Read

Altasciences completes acquisition of US-based CRO WCCT Global
Investment firm GI Partners closes Clinical Ink acquisition
Investment firm GI Partners to acquire minority interest in Clinical Ink

Most Recent

Clinical Trials

Altasciences completes acquisition of US-based CRO WCCT Global

19 Feb 2021
Companies
Sections

Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Most Read

Kolabtree
VaLea Clinical Trials
Linari NanoTech

Most Recent

Clinical Trials

Kolabtree

24 Feb 2021
Magazine
Events

Menu

News
Analysis
Investment
Sectors
Deals
Tech
Disruption
Coronavirus

Partners

Accelerating Clinical Trials
Simplifying Clinical Trials

Tools

Companies
Awards
Events
Magazine

The Company

About Us
Contact Us
Advertise With Us
Visit GlobalData

Login
Register

Login
Register

Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes

Lipaglyn is available in tablet form of 4mg dose.

Powered by

About Us
Editorial Approach
Contact Us
Terms and Conditions
Privacy Policy

© Copyright 2021 Verdict Media Limited.

Lost Password Back ⟶
Login
Register

Lost Password?

Registration is disabled.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Continue Learn more